Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
American Journal of Respiratory and Critical Care Medicine|May 16, 2015
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care UnitsGabriel T Bosslet, Thaddeus M Pope, Gordon D Rubenfeld, et al.
Journal of Palliative Medicine|November 5, 2013
Interprofessional communication skills training for serious illness: evaluation of a small-group, simulated patient interventionAlison M Bays, Ruth A Engelberg, Anthony L Back, et al.
Archives of Pathology & Laboratory Medicine|June 16, 2021
Interlaboratory Performance in Measurement of Dabigatran and RivaroxabanOksana Volod, Marian Rollins-Raval, Andrew J Goodwin, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2013
Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signalingYuanyuan Shi, Bernadette R Gochuico, Guoying Yu, et al.
Journal of Pain and Symptom Management|May 20, 2022
Evolution of Investigating Informed Assent Discussions about CPR in Seriously Ill PatientsRenee D Stapleton, Dee W Ford, Katherine R Sterba, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|October 28, 2021
Characteristics and Outcomes of US Patients Hospitalized With COVID-19Ithan D Peltan, Ellen Caldwell, Andrew J Admon, et al.
Critical Care Explorations|June 22, 2026
Impact of Fostamatinib on Inflammatory Biomarkers in Hospitalized Patients With COVID-19Raquel S Da Cruz, Heather L Teague, Marcos J Ramos-Benitez, et al.
JAMA Network Open|December 3, 2024
Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical TrialSean P Collins, Matthew S Shotwell, Jeffrey R Strich, et al.
The Lancet. Respiratory Medicine|June 22, 2023
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trialSamuel M Brown, Christina E Barkauskas, Birgit Grund, et al.
Pageof 10